Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $5.5 million.

  • Cellebrite DI's Non Operating Income rose 3107.91% to $5.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $24.2 million, marking a year-over-year increase of 10726.91%. This contributed to the annual value of $24.2 million for FY2025, which is 10726.91% up from last year.
  • As of Q4 2025, Cellebrite DI's Non Operating Income stood at $5.5 million, which was up 3107.91% from $5.3 million recorded in Q3 2025.
  • In the past 5 years, Cellebrite DI's Non Operating Income registered a high of $56.4 million during Q1 2022, and its lowest value of -$224.0 million during Q3 2024.
  • Moreover, its 5-year median value for Non Operating Income was $2.3 million (2021), whereas its average is -$11.5 million.
  • In the last 5 years, Cellebrite DI's Non Operating Income surged by 1530983.61% in 2022 and then tumbled by 468041.96% in 2023.
  • Quarter analysis of 5 years shows Cellebrite DI's Non Operating Income stood at $49.8 million in 2021, then tumbled by 101.15% to -$572000.0 in 2022, then crashed by 4680.42% to -$27.3 million in 2023, then skyrocketed by 115.25% to $4.2 million in 2024, then soared by 31.08% to $5.5 million in 2025.
  • Its Non Operating Income stands at $5.5 million for Q4 2025, versus $5.3 million for Q3 2025 and $6.4 million for Q2 2025.